Practice Guideline on Prevention, Diagnosis, and Treatment of Rhino-Orbito-Cerebral Mucormycosis in the COVID-19 Area: A Consensus of Iranian Experts
Archives of Clinical Infectious Diseases
; 17(4), 2022.
Article
in English
| EMBASE | ID: covidwho-2067097
ABSTRACT
Context The current pandemic of COVID-19 affected all people of the world. Evidence Acquisition Most complications of SARS-CoV-2 are causally related to severe pneumonia due to host immune response in the form of a cytokine storm. The other causes of an increased mortality rate among COVID-19 patients are secondary infections. Results:
Mucormycosis is a life-threatening infection that gained much attention in the ongoing COVID-19 pandemic. A rise in the frequency of COVID-19-associated mucormycosis (CAM) occurred in 2020 and 2021. Overall, mortality of CAM has been reported as 54%-75%.Conclusions:
Although awareness of the disease has increased among treating physicians, disease-associated morbidity and mortality are still high. The guideline is intended to serve as a reference to prevent mucormycosis in COVID-19 patients and help health-care providers choose diagnostic and treatment methods for the best management of CAM cases.
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Archives of Clinical Infectious Diseases
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS